RHYTHM PHARMACEUTICALS CEO Keith Gottesdiener's 2019 pay jumps 39% to $4.9M
RHYTHM PHARMACEUTICALS reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
RHYTHM PHARMACEUTICALS reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at RHYTHM PHARMACEUTICALS received on average a compensation package of $2.9M, a 33% increase compared to previous year.
Average pay of disclosed executives at RHYTHM PHARMACEUTICALS
Keith M. Gottesdiener, Chief Executive Officer, received $4.9M in total, which increased by 39% compared to 2018. 84% of Gottesdiener's compensation, or $4.1M, was in option awards. Gottesdiener also received $277K in non-equity incentive plan and $526K in salary.
Hunter C. Smith, Chief Executive Officer, received a compensation package of $1.9M, which increased by 21% compared to previous year. 67% of the compensation package, or $1.3M, was in option awards.
Nithya Desikan, Chief Commercial Officer, earned $1.8M in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.